Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

360 ARTÍCULOS , VIENDO DEL 316 AL 330

α-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential

Lichtenthaler SF.

J Neurochem. 2011 Jan;116(1):10-21. doi: 10.1111/j.1471-4159.2010.07081.x. Epub 2010 Dec 2.

Switching cholinesterase inhibitors in older adults with dementia

Massoud F, Desmarais JE, Gauthier S.

Int Psychogeriatr. 2011 Apr;23(3):372-8. doi: 10.1017/S1041610210001985. Epub 2010 Nov 3.

Natural products as a source of Alzheimer's drug leads

Williams P, Sorribas A, Howes MJ.

Nat Prod Rep. 2011 Jan;28(1):48-77. doi: 10.1039/c0np00027b. Epub 2010 Nov 12.

Roles of β-adrenergic receptors in Alzheimer's disease: implications for novel therapeutics

Yu JT, Wang ND, Ma T, Jiang H, Guan J, Tan L.

Brain Res Bull. 2011 Feb 1;84(2):111-7. doi: 10.1016/j.brainresbull.2010.11.004. Epub 2010 Dec 1.

Neuroprotective strategies involving ROS in Alzheimer disease

Dumont M, Beal MF.

Free Radic Biol Med. 2011 Sep 1;51(5):1014-26. doi: 10.1016/j.freeradbiomed.2010.11.026. Epub 2010 Dec 1.

Secretases as therapeutic targets for Alzheimer's disease

Woo HN, Baik SH, Park JS, Gwon AR, Yang S, Yun YK, Jo DG.

Biochem Biophys Res Commun. 2011 Jan 7;404(1):10-5. doi: 10.1016/j.bbrc.2010.11.132. Epub 2010 Dec 3.

Neurotherapeutic applications of nanoparticles in Alzheimer's disease

Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C.

J Control Release. 2011 Jun 10;152(2):208-31. doi: 10.1016/j.jconrel.2010.11.033. Epub 2010 Dec 4.

Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice

Rozkalne A, Hyman BT, Spires-Jones TL.

Neurobiol Dis. 2011 Mar;41(3):650-4. doi: 10.1016/j.nbd.2010.11.014. Epub 2010 Dec 4.

γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs

Oehlrich D, Berthelot DJ, Gijsen HJ.

J Med Chem. 2011 Feb 10;54(3):669-98. doi: 10.1021/jm101168r. Epub 2010 Dec 9.

Citicoline in vascular cognitive impairment and vascular dementia after stroke

Alvarez-Sabín J, Román GC.

Stroke. 2011 Jan;42(1 Suppl):S40-3. doi: 10.1161/STROKEAHA.110.606509. Epub 2010 Dec 16.

Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action

Barone E, Cenini G, Di Domenico F, Martin S, Sultana R, Mancuso C, Murphy MP, Head E, Butterfield DA.

Pharmacol Res. 2011 Mar;63(3):172-80. doi: 10.1016/j.phrs.2010.12.007. Epub 2010 Dec 27.

Targeting the hematopoietic system for the treatment of Alzheimer's disease

Lampron A, Gosselin D, Rivest S.

Brain Behav Immun. 2011 Jun;25 Suppl 1:S71-9. doi: 10.1016/j.bbi.2010.12.018. Epub 2010 Dec 30.

Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study

Kennelly SP, Abdullah L, Paris D, Parish J, Mathura V, Mullan M, Crawford F, Lawlor BA, Kenny RA.

Int J Geriatr Psychiatry. 2011 Oct;26(10):1038-45. doi: 10.1002/gps.2638. Epub 2010 Oct 29.

The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease

Mitchell RA, Herrmann N, Lanctôt KL.

CNS Neurosci Ther. 2011 Oct;17(5):411-27. doi: 10.1111/j.1755-5949.2010.00161.x. Epub 2010 Jun 16.

Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality

Ballard C, Creese B, Corbett A, Aarsland D.

Expert Opin Drug Saf. 2011 Jan;10(1):35-43. doi: 10.1517/14740338.2010.506711. Epub 2010 Aug 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias